Lonza
Salvatore Mercuri is an accomplished professional in the pharmaceutical industry, currently serving as Associate Director of NPI & MSAT and Head of Research and Development at Lonza since January 2018. Previously, Salvatore held positions as R&D Lab Manager and R&D Senior Scientist at MICRO-MACINAZIONE S.A. from February 2013 to December 2017. Salvatore's academic background includes a Ph.D. in Biopharmaceutics and Pharmacokinetics from the University of Parma and a postdoctoral research fellowship in the same department, focusing on innovative drug delivery technologies. Salvatore has also engaged in advanced studies at Université de Bourgogne. Educational qualifications include degrees in Industrial Pharmacy and relevant state exams for professional certifications, highlighting a strong foundation in pharmacy and chemistry.
This person is not in any teams
This person is not in any offices
Lonza
68 followers
Lonza Group AG (Lonza) is a Switzerland-based holding company and a supplier to the pharmaceutical, healthcare and life-science industries. The Company divides its activities into four divisions: Life Science Ingredients; Microbial Control; Custom Manufacturing, and Bioscience. The Life Science Ingredients division comprises a range of products for applications in nutrition, hygiene, preservation, water treatment, materials protection, and other industrial markets. The Microbial Control division focuses on five areas: hygiene, wood protection, water treatment, oil/gas applications, and industrial preservation and comprises products ranging from disinfectants to household cleaning products. The Custom Manufacturing division comprises products used in pharmaceuticals sector. The Bioscience division comprises bioscience products, including cell culture and molecular biology tools for research, tests for microbial detection, and media used in the production of therapeutics.